Skip to main content
OpenTrials
Completed

NCT Number: NCT01986621

Myocardial Injury After Elective Coronary Stenting

This pilot study aims to identify patients at moderate to high risk for peri-procedural (type 4) myocardial infarction or injury after after undergoing an elective coronary intervention (PCI) as measured by high sensitivity troponin T, who might benefit from more potent antiplatelet therapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Cardiology - University Hospital of Heidelberg

Heidelberg, 69120, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stable or unknown coronary artery disease (CAD)
  • Elective coronary intervention
  • Minimum age of 18

Exclusion criteria

  • Present acute coronary syndrome (ACS)
  • Age under 18
  • Pregnancy
  • Any additional invasive intervention with potential myocardial injury
  • Non ACS conditions responsible for elevation of cardiac troponin, such as acute pulmonary artery embolism, myocarditis or tachycardia.

Treatment and study plan

Primary outcomes

  1. Postprocedural myocardial infarction (type 4a) or injury

    Time frame: up to 72 hours after procedure

Sponsors and collaborators

Lead sponsor

University Hospital Heidelberg

Other

Collaborators

  • AstraZeneca

Registry information

Official study title

Identification of Patients at Higher Risk for Myocardial Injury or Type 4a Infarction Following Elective Coronary Artery Stenting

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Nov 18, 2013
Registry last updated
May 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.